Thyroid News

The thyroid cancer rate has remained steady since 1980 among Danish children and adolescents, but diagnoses among patients aged 18 to 24 years have grown, with specific increases among women and those with papillary carcinoma, according to findings published in Thyroid.

Researchers have observed an increasing prevalence of neonatal thyroid-stimulating hormone levels greater than 2 mIU/L in Northern Ireland, suggesting an emerging modest iodine deficiency in the region, according to findings published in Clinical Endocrinology.

Among adults with hypothyroidism, those with congestive heart failure are more likely and those without are less likely to be hospitalized compared with euthyroid adults, according to findings published in Thyroid.

Exposure to high levels of air pollution in pregnancy may have subtle influences on the development of the fetal thyroid gland and its subsequent function, according to findings published in JAMA Network Open.

Combining the eighth edition of the American Joint Committee on Cancer staging system and the American Thyroid Association risk classification system can provide more precise estimates of recurrence risk and disease-specific survival for patients with thyroid cancer, according to findings published in Thyroid.

Cases of thyroid cancer are increasing, according to the American Cancer Society.

Ultrasound radiomic analysis may better predict malignant thyroid lesions than visual interpretations of thyroid nodules by junior radiologists using the American College of Radiology’s scoring criteria, according to a retrospective analysis published in Thyroid.

The FDA granted breakthrough therapy designation to LOXO-292, a selective RET inhibitor, for the treatment certain patients with RET-altered non-small cell lung cancer or medullary thyroid cancer, according to the agent’s manufacturer.

The eighth edition of the American Joint Committee on Cancer/tumor node metastasis staging system for differentiated thyroid cancer was a better predictor of overall and disease-specific survival than the seventh edition of the staging system regardless of cancer subtype, according to data published in Thyroid.

For adults aged 55 years and older, tumor size can be an accurate means to predict recurrence of papillary thyroid carcinoma, with every 1-cm increase equating to a 52% increase in recurrence risk, according to study findings.